Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Median effective dose of ciprofol infusion with different esketamine doses during gastrointestinal endoscopy
ChiCTR2400093995Phase 4Completed
- Sponsor
- Shidong Hospital
- Start
- Dec 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol and esketamine in None (3 arms), sponsored by Shidong Hospital. Primary endpoints: Blood pressure and Heart rate. Started Dec 2024; status: completed.
02
Drugs
ciprofolesketamine
Beyond the preview
Go deeper on ChiCTR2400093995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093995.